about
Indications for the use of diagnostic implantable and external ECG loop recorders.Therapeutic and diagnostic role of electrical devices in acute heart failure.Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management.What are the costs of heart failure?Cardiac resynchronization therapy: a breakthrough in heart failure management.Effects of prolonged exercise on left ventricular mechanical synchrony in long-distance runners: importance of previous exposure to endurance races.Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.Changes in right ventricular pressures between hemodialysis sessions recorded by an implantable hemodynamic monitor.Predisposing factors and consequences of elevated biomarker levels in long-distance runners aged >or=55 years.Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure.Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy.Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry.Women have better long-term prognosis than men after cardiac resynchronization therapy.Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario.Cryoablation of substrates adjacent to the atrioventricular node: acute and long-term safety of 1303 ablation procedures.[Chronic rhinosinusitis and aspirin intolerance]Continuous warfarin therapy is safe and feasible in catheter ablation of atrial fibrillation.An advanced modelling tool for simulating complex river systems.When cardiac function dangles on a thread of conduction: dyssynchronopathy in patients with left bundle branch block.Cardiac resynchronization therapy in the intensive care setting; the promise and peril of using implantable devices off label.Preparticipation evaluation of novice, middle-age, long-distance runners.Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy.Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad.Electromechanical effects of cardiac resynchronization therapy during rest and stress in patients with heart failure.Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure.Altered ventriculo-arterial coupling during exercise in athletes releasing biomarkers after endurance running.Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels.Cardiac fatigue in long-distance runners is associated with ventricular repolarization abnormalities.Performance trends and cardiac biomarkers in a 30-km cross-country race, 1993-2007.Magnitude, reproducibility, and association with baseline cardiac function of cardiac biomarker release in long-distance runners aged > or =55 years.Devices in heart failure: building up the evidence.Ambulatory hemodynamic monitoring from an implanted device: components of continuous 24-hour pressures that correlate to supine resting conditions and acute right heart catheterization.Three year outcome of cardiac resynchronization therapy: a single center evaluation.Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor.Paroxysmal regular supraventricular tachycardia: the diagnostic accuracy of the transesophageal ventriculo-atrial interval.Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices.Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure.Estimating changes in cardiac output using an implanted hemodynamic monitor in heart failure patients.Optimization of cardiac resynchronization therapy by continuous hemodynamic monitoring:.Overcoming the resistance to impedance monitoring in heart failure patients.
P50
Q33157361-95DE3471-04FB-44F7-B836-D498830746D0Q36796946-2760AFE6-25CB-4CE3-BFCE-844CED96D2C0Q37803046-FA8A99DC-4B09-4807-9808-C07AE7B687FCQ37868827-8BD7EAD1-8BD3-4BB7-B1E3-9C2EDC022851Q38033683-961423DB-355B-481A-A8DA-19B8C819F57CQ39850079-F5AB38EE-4EDC-48F3-85BB-030F3C3B2EB1Q39895758-C2EA6AD2-7A6B-4D6F-BAF1-E20104530656Q40016655-FA114A71-F841-4F10-A598-4F2EC5FD3692Q43247847-093676C4-E522-482C-8999-52ECFD802B31Q43821138-D67F3CA5-728B-45AB-8A7C-695F73284600Q43968618-80EE893C-76AF-4D1D-A347-B2C39A56C041Q43998937-FA38EE0A-72F3-4CE9-B12E-7001EE1CE3E9Q44159690-3D75C76E-4247-40AC-9CA9-F96ABDB8D168Q45350994-48AA5E06-56A2-48FE-87C8-FAF5FC81DE5EQ45893343-EF8D5458-C3A0-46F3-AEBA-F15419BCA991Q46038109-2850F465-9082-424E-A5D6-BA25E46BDD2EQ46434528-3FF64376-2262-4C94-8113-62FF607E53EBQ46694628-79F6F756-BFF0-4F90-B0DD-C2C9578DC10DQ46846259-7E1FF519-C0F3-4AC6-A81C-7CD884B396DDQ47875699-490F9903-77AE-4766-B3CB-3F10B660696CQ47966605-AAD030B0-5F37-43F8-A603-0CC15F9FC3CBQ48231366-3A7E29B9-9036-4E4D-9AE6-AC7D9668B0D8Q48243802-E21BF282-A7E5-451E-A7D2-88AD131E65CAQ48249765-952C373C-78F4-4A0D-8909-56BAA326A2B5Q48528279-EA7FD3B5-0ECE-411A-892A-D94E5556C277Q48582967-73A14E2C-FCC4-4074-BC66-F861429F7B88Q48627966-84778DFA-75C6-4E12-8600-713280B07896Q48686668-6604A6F1-3B25-40D3-B745-B8ACAC4347EEQ48832303-D2758253-ECE5-4A81-8537-DA9446E14EAFQ49119255-66643AC5-9AE1-4499-9AB0-CC922BA48F5FQ51119505-41D107B0-BF32-433E-ADD4-EE797135D70DQ51273915-1B16219F-933D-4F42-B01E-2D5EEE09DF90Q51339947-E0AA0141-9553-4B60-8803-79E087FF7102Q51359674-F21E3B19-9F4F-44F8-AA53-DF9269C9E42FQ51400427-55DB1CFE-FE98-460D-8322-3EBF32FEF621Q51496363-EC26D052-6F40-4865-8FE7-91E8769242EEQ51524674-DEA62EE5-0F99-4D6E-B754-56304BCA8E60Q51699343-98ED2427-D6FC-4C38-B2FB-14B7A053D818Q51700656-32888D71-D5BC-4A83-AC61-E8CD026F4355Q51714984-B1725C56-56F7-449A-885F-0928300F27EB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Frieder Braunschweig
@ast
Frieder Braunschweig
@en
Frieder Braunschweig
@es
Frieder Braunschweig
@nl
Frieder Braunschweig
@sl
type
label
Frieder Braunschweig
@ast
Frieder Braunschweig
@en
Frieder Braunschweig
@es
Frieder Braunschweig
@nl
Frieder Braunschweig
@sl
prefLabel
Frieder Braunschweig
@ast
Frieder Braunschweig
@en
Frieder Braunschweig
@es
Frieder Braunschweig
@nl
Frieder Braunschweig
@sl
P106
P21
P31
P496
0000-0002-4966-1315